Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Dupixent
Research
Dupixent for cancer? Researchers test med as PD-1 booster
Pairing Dupixent with PD-1 inhibitors slowed tumor growth in mouse models and stabilized disease in some patients in a small clinical trial.
Helen Floersh
Dec 7, 2023 6:00am
Celldex laces up next to Big Pharmas with chronic hive drug
Nov 6, 2023 10:17am
2 biotechs test icy IPO waters with $228M and $66M offerings
Jul 10, 2023 11:43am
Aslan hopes to take on Dupixent in AD with fewer side effects
Jul 6, 2023 11:20am
Revolo drops dab of midphase data on would-be Dupixent rival
Apr 19, 2023 9:30am
Obesity may alter inflammation on a molecular level
Apr 4, 2022 11:52am
